Dimple Chakravarty
Dimple Chakravarty
Verified email at mountsinai.org
Cited by
Cited by
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
Nat Commun. 5 (5383), 2014
Role of non-coding sequence variants in cancer
E Khurana, Y Fu, D Chakravarty, F Demichelis, MA Rubin, M Gerstein
Nature Reviews Genetics 17 (2), 93-108, 2016
Integrative annotation of variants from 1092 humans: application to cancer genomics
E Khurana, Y Fu, V Colonna, XJ Mu, HM Kang, T Lappalainen, A Sboner, ...
Science 342 (6154), 1235587, 2013
Whole-exome sequencing of metastatic cancer and biomarkers of treatment response
H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ...
JAMA oncology 1 (4), 466-474, 2015
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor‐α target gene activation by regulating lysine demethylase 1 specificity
SS Nair, BC Nair, V Cortez, D Chakravarty, E Metzger, R Schüle, ...
EMBO reports 11 (6), 438-444, 2010
Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells
D Chakravarty, SS Nair, B Santhamma, BC Nair, L Wang, ...
Cancer research 70 (10), 4092-4101, 2010
Significance of ER–Src axis in hormonal therapy resistance
S Vallabhaneni, BC Nair, V Cortez, R Challa, D Chakravarty, RR Tekmal, ...
Breast cancer research and treatment 130 (2), 377-385, 2011
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
D Chakravarty, SS Nair, N Hammouda, P Ratnani, Y Gharib, V Wagaskar, ...
Communications biology 3 (1), 1-12, 2020
Exercise apparatus
DL Keiser
US Patent 7,172,538, 2007
Identification of functionally active, low frequency copy number variants at 15q21. 3 and 12q21. 31 associated with prostate cancer risk
F Demichelis, SR Setlur, S Banerjee, D Chakravarty, JYH Chen, CX Chen, ...
Proceedings of the National Academy of Sciences 109 (17), 6686-6691, 2012
Significance of PELP1 in ER-negative breast cancer metastasis
S Roy, D Chakravarty, V Cortez, K De Mukhopadhyay, A Bandyopadhyay, ...
Molecular Cancer Research 10 (1), 25-33, 2012
Role of PELP1/MNAR signaling in ovarian tumorigenesis
C Dimple, SS Nair, R Rajhans, PR Pitcheswara, J Liu, S Balasenthil, ...
Cancer research 68 (12), 4902-4909, 2008
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis
D Chakravarty, SS Roy, CR Babu, R Dandamudi, TJ Curiel, P Vivas-Mejia, ...
Clinical Cancer Research 17 (8), 2250-2259, 2011
Cyclin-Dependent Kinase–Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1
BC Nair, SS Nair, D Chakravarty, R Challa, B Manavathi, PR Yew, ...
Cancer research 70 (18), 7166-7175, 2010
Estrogen receptor β1 and the β2/βcx isoforms in nonneoplastic endometrium and in endometrioid carcinoma
D Chakravarty, R Srinivasan, S Ghosh, S Gopalan, A Rajwanshi, ...
International Journal of Gynecologic Cancer 17 (4), 2007
Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes
E Rheinbay, MM Nielsen, F Abascal, G Tiao, H Hornshĝj, JM Hess, ...
BioRxiv, 237313, 2017
PELP1: A novel therapeutic target for hormonal cancers
D Chakravarty, RR Tekmal, RK Vadlamudi
IUBMB life 62 (3), 162-169, 2010
Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway
JK Nagpal, S Nair, D Chakravarty, R Rajhans, S Pothana, DW Brann, ...
Molecular Cancer Research 6 (5), 851-861, 2008
Integrin-linked kinase 1: role in hormonal cancer progression
V Cortez, BC Nair, D Chakravarty, RK Vadlamudi
Frontiers in bioscience (scholar edition) 3, 788, 2011
The system can't perform the operation now. Try again later.
Articles 1–20